India covid-19 vaccine Health India

WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries

Reading now: 922
www.who.int

Today, the World Health Organization issued and emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus.

The vaccine, named CovovaxTM, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio, giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries.

WHO’s EUL procedureassesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX vaccine supply.

It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. “Even with new variants emerging, vaccines remain one of the most effective tools to protect

Read more on who.int
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA